Historical record - last NADAC effective date: 2/19/2020
Product Information
RANITIDINE 300 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.5821 per EA under NDC 27241011003. Its NADAC has been published 103 times since Feb 27, 2019.
FDA first approved this application on Sep 27, 2018.
The High Outlier badge above means this manufacturer's average price in the Ranitidine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241011003
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/19/2020
Active Ingredients
RANITIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209859FDA Approved
9/27/2018
On Market Since
9/27/2018
Pharmacological Classes
Price Statistics
The NADAC for RANITIDINE 300 MG CAPSULE has been published 103 times since Feb 27, 2019, and over the history we have for it it has declined 45.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5821 per EA |
|---|---|
| All-time high | $1.0649 (Mar 13, 2019) |
| All-time low | $0.5821 (Feb 19, 2020) |
| Median price | $0.5821 |
| Average price | $0.7203 |
| Largest weekly change | +45.8% (May 22, 2019) |
| Weeks tracked | 103 |
| Tracking since | Feb 27, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-45.3%
Last surveyed Feb 10, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RANITIDINE 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RANITIDINE 300 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.5821 per EA (NDC 27241011003), effective Feb 10, 2021.
How has the price of RANITIDINE 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RANITIDINE 300 MG CAPSULE has declined 45.3%. It has been tracked across 103 weekly CMS publications since Feb 27, 2019.
What are the highest and lowest recorded NADAC prices for RANITIDINE 300 MG CAPSULE?
Since Feb 27, 2019, the NADAC for RANITIDINE 300 MG CAPSULE has ranged from a low of $0.5821 (Feb 19, 2020) to a high of $1.0649 (Mar 13, 2019), with a median of $0.5821 per EA.
Are there cheaper alternatives to RANITIDINE 300 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RANITIDINE 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RANITIDINE 300 MG CAPSULE?
RANITIDINE 300 MG CAPSULE (NDC 27241011003) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.